BMS-536924 5mg 5mg | Purity Not Available
Adooq Bioscience
BMS-536924 is an effective inhibitor of IGF-IR, causing a reversion of an IGF-IR – mediated transformed phenotype.
More Information Supplier PageBMS-536924 is an effective inhibitor of IGF-IR, causing a reversion of an IGF-IR – mediated transformed phenotype.
More Information Supplier PageBMS-536924 is an effective inhibitor of IGF-IR, causing a reversion of an IGF-IR – mediated transformed phenotype.
More Information Supplier PageBMS-536924 is an effective inhibitor of IGF-IR, causing a reversion of an IGF-IR – mediated transformed phenotype.
More Information Supplier PageBMS-536924 is an effective inhibitor of IGF-IR, causing a reversion of an IGF-IR – mediated transformed phenotype.
More Information Supplier PageOSI-906 is a potential first-in-class selective small molecule, dual kinase inhibitor of both insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR).
More Information Supplier PageOSI-906 is a potential first-in-class selective small molecule, dual kinase inhibitor of both insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR).
More Information Supplier PageOSI-906 is a potential first-in-class selective small molecule, dual kinase inhibitor of both insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR).
More Information Supplier PageOSI-906 is a potential first-in-class selective small molecule, dual kinase inhibitor of both insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR).
More Information Supplier PageAMG-458 is a potent inhibitor of c-Met with an IC50 value of 60nM and displays selectivity against VEGFR2.
More Information Supplier PageAMG-458 is a potent inhibitor of c-Met with an IC50 value of 60nM and displays selectivity against VEGFR2.
More Information Supplier Page